Optic Neuritis Possibly Induced by Anti-PD-L1 Antibody Treatment in a Patient with Non-Small Cell Lung Carcinoma

Optic Neuritis Possibly Induced by Anti-PD-L1 Antibody Treatment in a Patient with Non-Small Cell Lung Carcinoma

Background: Recent immune therapy with checkpoint inhibitors (CPIs) has demonstrated remarkable antitumor effects on specific tumors, such as malignant lymphoma and non-small cell lung carcinoma. By contrast, CPIs cause an imbalance in the immune system, triggering a wide range of immunological side...

Full description

Bibliographic Details
Main Authors: Sotaro Mori, Takuji Kurimoto, Kaori Ueda, Hiroko Enomoto, Mari Sakamoto, Yukako Keshi, Yuko Yamada, Makoto Nakamura
Format: Article
Language:English
Published: Karger Publishers 2018-07-01
Series:Case Reports in Ophthalmology
Subjects:
Optic neuritis
Anti-PD-L1 antibody
Immune-related adverse effects
Hypopituitarism
Online Access:https://www.karger.com/Article/FullText/491075

Internet

https://www.karger.com/Article/FullText/491075

Similar Items